Press Releases
Search
-
26 Jun 2019
bioMérieux et l’État de Côte d’Ivoire inaugurent le Centre de formation bioMérieux et signent un accord de collaboration
L’État de Côte d’Ivoire et bioMérieux, acteur mondial du diagnostic in vitro, annoncent la signature d’un mémorandum d’accord de collaboration à l’occasion de l’inauguration du Centre de formation de ...
-
06 Jun 2019
bioMérieux increases its holding in Hybiome from 54% to 67%
bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier...
-
13 May 2019
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”
The NEPHROCHECK® Test biomarkers (TIMP-2 and IGFBP7) that indicate kidney stress in advance of acute kidney injury (AKI) have been included in the “Guidelines for Perioperative Care in Cardiac Surgery...
-
24 Apr 2019
bioMérieux – First-Quarter 2019 Business Review
Organic growth of 3.8% (at constant exchange rates and scope of consolidation) €632 million in sales Up 7.7% as reported Growth led by the performance in molecular biology, during a first quarter shap...
-
15 Apr 2019
“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients
bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology...
-
02 Apr 2019
University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicine...
-
19 Mar 2019
Baxter et bioMérieux annoncent leur collaboration pour améliorer l'identification et le traitement de l’insuffisance rénale aiguë
Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the g...
-
27 Feb 2019
bioMérieux – 2018 Financial Results
Organic sales growth of 9.9% for full-year 2018: €2,421 million in sales Up 5.8% as reported Solid fourth-quarter performance, with organic growth of more than 10% Improvement in contributive operatin...
-
07 Feb 2019
bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) d...
-
19 Dec 2018
bioMérieux receives FDA clearance for BPA and BPN culture bottles used with BACT/ALERT® VIRTUO® for quality control testing of platelets
bioMérieux, a world leader in the field of in vitro diagnostics, announces that its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (F...
-
13 Nov 2018
bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the Food and Drug Administration (FDA) 510(k) clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel and the CE-Mark of t...
-
09 Nov 2018
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the ac...
-
18 Oct 2018
Business review for the nine months ended September 30, 2018
Strong sales dynamic confirmed in third quarter, with an 8.8% increase in organic sales Growth of 9.8% at constant exchange rates and scope of consolidation over the nine months ended September 30: €1...
-
25 Sep 2018
bioMérieux commitments in the CDC’s “AMR Challenge”, a joint public-private sector initiative to accelerate the fight against antimicrobial resistance
Marcy l’Étoile (France) – Sept. 25, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, is participating in the AMR Challenge, a new Centers for Disease Control and Prevention (CDC...
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...